Roberto Borea

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Squamous Cell Carcinoma

Radical Prostatectomy

Dna Damage Response

Top Venues

Expert review of anticancer therapy

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Arecco, Roberto Borea, Isotta Martha Magaton, Kristina Janković, Elene Mariamizde, Mihaela Stana, Graziana Scavone, Silvia Ottonello, Stefano Spinaci, Carlo Genova, Evandro de Azambuja, Matteo Lambertini
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer. Expert review of anticancer therapy (2024)
Luca Arecco, Roberto Borea, Isotta Martha Magaton, Kristina Janković, Elene Mariamizde, Mihaela Stana, Graziana Scavone, Silvia Ottonello, Stefano Spinaci, Carlo Genova, Evandro de Azambuja, Matteo Lambertini
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer. Expert review of anticancer therapy 24 (9) (2024)
Graziana Scavone, Silvia Ottonello, Eva Blondeaux, Luca Arecco, Paola Scaruffi, Sara Stigliani, Barbara Cardinali, Roberto Borea, Michele Paudice, Valerio Gaetano Vellone, Margherita Condorelli, Isabelle Demeestere, Matteo Lambertini
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition. Cancers 15 (20) (2023)
Roberto Borea, Diletta Favero, Alberto Miceli, Maria Isabella Donegani, Stefano Raffa, Annalice Gandini, Malvina Cremante, Cecilia Marini, Gianmario Sambuceti, Elisa Zanardi, Silvia Morbelli, Giuseppe Fornarini, Sara Elena Rebuzzi, Matteo Bauckneht
Beyond the Prognostic Value of 2-[ 18 F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management. Diagnostics (Basel, Switzerland) 12 (3) (2022)
Fabio Catalano, Roberto Borea, Silvia Puglisi, Andrea Boutros, Annalice Gandini, Malvina Cremante, Valentino Martelli, Stefania Sciallero, Alberto Puccini
Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer. Cancers 14 (6) (2022)
Bruna Dalmasso, Alberto Puccini, Fabio Catalano, Roberto Borea, Maria Laura Iaia, William Bruno, Giuseppe Fornarini, Stefania Sciallero, Sara Elena Rebuzzi, Paola Ghiorzo
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients. International journal of molecular sciences 23 (9) (2022)
Roberto Borea, Alessandra Damassi, Sara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, Fabio Catalano, Valentino Martelli, Giuseppe Fornarini
Immunotherapy retreatment: case report, review of the literature and proposal for the definition of different scenarios. Immunotherapy 13 (8) (2021)
Marco Tagliamento, Elisa Agostinetto, Roberto Borea, Mariana Brandão, Francesca Poggio, Alfredo Addeo, Matteo Lambertini
VISTA: A Promising Target for Cancer Immunotherapy? ImmunoTargets and therapy 10 (2021)
Guido Pesola, Veronica Murianni, Sara Elena Rebuzzi, Giuseppe Luigi Banna, Luigi Cerbone, Fabio Catalano, Roberto Borea, Annalice Gandini, Malvina Cremante, Silvia Puglisi, Francesco Trovato, Giuseppe Fornarini
Durable response after immunotherapy discontinuation for delayed and severe immune-related adverse events: a case report. Immunotherapy 13 (17) (2021)
Jonathan Fisher, Roshan Sharma, Dilu Wisidagamage Don, Marta Barisa, Marina Olle Hurtado, Pierre Abramowski, Lucy Porter, William Day, Roberto Borea, Sarah Inglott, John Anderson, Dana Pe'er
Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors. Science signaling 12 (598) (2019)